Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.

Benzer Materyaller

• Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
  Yazar:: Shipman, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
  Yazar:: Croucher, P, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Cells of the bone marrow microenvironment protect myeloma cells from apoptosis induced by TRAIL but not by agonists of TRAIL death receptors.
  Yazar:: Locklin, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Role of osteoprotegerin (OPG) in cancer.
  Yazar:: Holen, I, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
  Yazar:: Shipman, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)